CR20140345A - Nuevas formas y sales de un dihidropirrolo [1,2-c] imidazolilo, inhibidor de la aldosterona sintasa o aromatasa - Google Patents

Nuevas formas y sales de un dihidropirrolo [1,2-c] imidazolilo, inhibidor de la aldosterona sintasa o aromatasa

Info

Publication number
CR20140345A
CR20140345A CR20140345A CR20140345A CR20140345A CR 20140345 A CR20140345 A CR 20140345A CR 20140345 A CR20140345 A CR 20140345A CR 20140345 A CR20140345 A CR 20140345A CR 20140345 A CR20140345 A CR 20140345A
Authority
CR
Costa Rica
Prior art keywords
salts
imidazolilo
dihydropirrolo
sintasa
aldosterone
Prior art date
Application number
CR20140345A
Other languages
English (en)
Inventor
Paul Sutton
Eric Loeser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47604250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20140345(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CR20140345A publication Critical patent/CR20140345A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a una sal de fosfato o una sal de nitrato de 4 - (R) - 6,7- dihidro-5H- pirrolo [1,2- c] imidazol- 5- il- 3- fluoro- benzonitrilo, con la siguiente fórmula: especialmente en forma cristalina, y formas específicas de estas sales, a
CR20140345A 2012-01-17 2014-07-17 Nuevas formas y sales de un dihidropirrolo [1,2-c] imidazolilo, inhibidor de la aldosterona sintasa o aromatasa CR20140345A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261587280P 2012-01-17 2012-01-17

Publications (1)

Publication Number Publication Date
CR20140345A true CR20140345A (es) 2014-09-09

Family

ID=47604250

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140345A CR20140345A (es) 2012-01-17 2014-07-17 Nuevas formas y sales de un dihidropirrolo [1,2-c] imidazolilo, inhibidor de la aldosterona sintasa o aromatasa

Country Status (40)

Country Link
US (2) US9334276B2 (es)
EP (1) EP2804863B1 (es)
JP (1) JP5749410B2 (es)
KR (2) KR20140141687A (es)
CN (1) CN104039793B (es)
AP (1) AP2014007762A0 (es)
AR (1) AR089728A1 (es)
AU (1) AU2013209952B2 (es)
BR (1) BR112014017260A8 (es)
CA (1) CA2863339C (es)
CL (1) CL2014001863A1 (es)
CO (1) CO7000775A2 (es)
CR (1) CR20140345A (es)
CU (1) CU20140086A7 (es)
CY (1) CY1117914T1 (es)
DK (1) DK2804863T3 (es)
EA (1) EA026232B1 (es)
ES (1) ES2564143T3 (es)
GT (1) GT201400155A (es)
HR (1) HRP20160178T1 (es)
HU (1) HUE026984T2 (es)
IL (1) IL233541B (es)
IN (1) IN2014DN06781A (es)
JO (1) JO3137B1 (es)
MA (1) MA35858B1 (es)
MX (1) MX2014008686A (es)
NZ (1) NZ626277A (es)
PE (1) PE20142358A1 (es)
PH (1) PH12014501638A1 (es)
PL (1) PL2804863T3 (es)
RS (1) RS54589B1 (es)
SG (1) SG11201404061YA (es)
SI (1) SI2804863T1 (es)
SM (1) SMT201600083B (es)
TN (1) TN2014000256A1 (es)
TW (1) TWI609869B (es)
UA (1) UA114803C2 (es)
UY (1) UY34576A (es)
WO (1) WO2013109514A1 (es)
ZA (1) ZA201404314B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE041967T2 (hu) * 2010-01-14 2019-06-28 Novartis Ag Mellékvese hormon-módosító szer alkalmazása
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
PH12016502540B1 (en) 2014-07-07 2022-07-20 Recordati Ag Pharmaceutical dosage forms
MX2017009839A (es) * 2015-01-29 2017-11-02 Novartis Ag Proceso para la produccion de derivados de imidazolo condensados.
WO2016164476A2 (en) * 2015-04-06 2016-10-13 Millendo Therapeutics, Inc. Combination therapy for treating disorders associated with excess cortisol production
WO2018078049A1 (en) * 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
CN109890389B (zh) * 2016-10-27 2022-07-01 达米安制药股份公司 醛固酮合酶抑制剂
JP7470050B2 (ja) 2018-05-03 2024-04-17 ダミアン ファーマ アーゲー アルドステロン症の治療における使用のためのr-ファドロゾール

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1315449A (en) * 1918-11-15 1919-09-09 Frank B Yingling Shaper-feed.
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5066656A (en) 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
MTP1076B (en) 1990-01-12 1991-09-30 Ciba Geigy Ag Hemihydrate
CA2127689A1 (en) 1992-01-27 1993-08-05 Marcel A. C. Janssen Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors
WO2004046145A1 (en) 2002-11-18 2004-06-03 Novartis Ag Imidazo[1, 5a]pyridine derivatives and methods for treating aldosterone mediated diseases
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
CN101578272A (zh) 2006-12-18 2009-11-11 诺瓦提斯公司 1-取代的咪唑衍生物和它们作为醛固酮合酶抑制剂的用途
ES2472446T3 (es) 2009-11-30 2014-07-01 Novartis Ag Derivados de imidazol como inhibidores de aldosterona sintasa
HUE041967T2 (hu) * 2010-01-14 2019-06-28 Novartis Ag Mellékvese hormon-módosító szer alkalmazása

Also Published As

Publication number Publication date
HUE026984T2 (en) 2016-08-29
TN2014000256A1 (en) 2015-09-30
US20160176883A1 (en) 2016-06-23
GT201400155A (es) 2017-09-28
IN2014DN06781A (es) 2015-05-22
PE20142358A1 (es) 2015-01-30
ZA201404314B (en) 2015-08-26
TW201335161A (zh) 2013-09-01
AU2013209952A1 (en) 2014-07-24
CL2014001863A1 (es) 2014-11-07
DK2804863T3 (en) 2016-03-07
UY34576A (es) 2013-09-02
KR20140141687A (ko) 2014-12-10
PH12014501638B1 (en) 2014-10-13
MA35858B1 (fr) 2014-12-01
HK1198536A1 (en) 2015-05-15
KR20140093726A (ko) 2014-07-28
CN104039793B (zh) 2017-05-10
CA2863339C (en) 2021-03-23
IL233541B (en) 2018-12-31
TWI609869B (zh) 2018-01-01
IL233541A0 (en) 2014-08-31
MX2014008686A (es) 2014-08-27
EP2804863A1 (en) 2014-11-26
AR089728A1 (es) 2014-09-10
WO2013109514A1 (en) 2013-07-25
JO3137B1 (ar) 2017-09-20
SI2804863T1 (sl) 2016-05-31
EP2804863B1 (en) 2015-12-02
BR112014017260A2 (pt) 2017-06-13
ES2564143T8 (es) 2020-11-18
SMT201600083B (it) 2016-04-29
CO7000775A2 (es) 2014-07-21
JP2015503627A (ja) 2015-02-02
RS54589B1 (sr) 2016-08-31
HRP20160178T1 (hr) 2016-03-25
UA114803C2 (uk) 2017-08-10
JP5749410B2 (ja) 2015-07-15
NZ626277A (en) 2015-10-30
AP2014007762A0 (en) 2014-07-31
CU20140086A7 (es) 2014-12-26
PL2804863T3 (pl) 2016-06-30
PH12014501638A1 (en) 2014-10-13
AU2013209952B2 (en) 2016-09-01
US20140364470A1 (en) 2014-12-11
ES2564143T3 (es) 2016-03-18
CN104039793A (zh) 2014-09-10
SG11201404061YA (en) 2014-08-28
CA2863339A1 (en) 2013-07-25
EA026232B1 (ru) 2017-03-31
BR112014017260A8 (pt) 2017-07-04
EA201491374A1 (ru) 2014-12-30
CY1117914T1 (el) 2017-05-17
US9334276B2 (en) 2016-05-10

Similar Documents

Publication Publication Date Title
CR20140345A (es) Nuevas formas y sales de un dihidropirrolo [1,2-c] imidazolilo, inhibidor de la aldosterona sintasa o aromatasa
UY33985A (es) Sales de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida
SMT201600023B (it) Composti piridazinonici e loro uso come inibitori di daao
IL239116B (en) New bicyclic compounds, and their use as antibacterial agents and as beta-lactamase inhibitors
EP2788000A4 (en) PYRROLOPYRIMIDINES AS JANUSKINASEINHIBITORS
SMT201500265B (it) Composti di pirrolopirimidina quali inibitori di cdk4/6
UY34004A (es) INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO[2,3-d]PIRIMIDINA TROPOMIOSINA
CO6831982A2 (es) Pirazolo[4,3-d]pirimidinas útiles como inhibidores de cinasas
AP3849A (en) Use of inhibitors of the activity or function of pi3k
SG10201605196PA (en) Novel Inhibitor Compounds Of Phosphodiesterase Type 10A
BR112013025354A2 (pt) combinações de compostos de inibidor de akt e agentes quimioterápicos e métodos de uso
EP2934535A4 (en) SUBSTITUTED PYRROLOPYRIMIDINES AS HDM2 INHIBITORS
SMT201400106B (it) Inibitori di met per incrementare l'efficacia della radioterapia
HRP20182043T8 (hr) Upotreba anti-koneksinskih sredstava za poboljšanje terapijskog učinka inhibitora acetilkolinesteraze
ZA201406038B (en) Substituted pyrimidine compounds and their use as syk inhibitors
MA35439B1 (fr) Inhibiteurs de l'enzyme activant nedd8
EP2714967A4 (en) ANTI-CORROSIVE ELECTROCOATING
MX359673B (es) Preparacion de intermediarios de pirimidina utiles para la preparacion de maci tentano.
MX2014010423A (es) Sales de arginina utiles inmunologicamente.
ITUD20110217A1 (it) Apparato per l'incasso di una bobina e valvola idraulica azionata a pilota che incorpora lo stesso
ZA201501458B (en) Novel inhibitor compounds of phosphodiesterase type 10a
MX373441B (es) Derivados de indol-urea glucopiranosil-sustituido y su uso como inhibidores sglt.
SG11201504115XA (en) Novel inhibitor compounds of phosphodiesterase type 10a
UA106105C2 (uk) Застосування похідних 2-оксоіндолін-3-гліоксилової кислоти як засобів з антидепресивною дією
UY33803A (es) Formas de dosificación de liberación modificada novedosas de inhibidor de xantina oxidorreductasa o inhibidores de xantina oxidasa